8 October 2024 Seminars

• Integrating AI within the early stages to accelerate and optimize clinical trial design
• Exploring how AI technology can be implemented within minor areas to enhance overall clinical outcomes
• Analyzing technical skills and knowledge gaps to enhance training and ensure proper use of tools and data
• Will AI replace people or train people?

• Finding the Right Places: Figuring out the right countries and sites to conduct your clinical trial
• Understanding Local Factors: Considering patient population, healthcare infrastructure, and regulatory environment in different countries
• Leveraging real world data to support recruitment of diverse populations
• Enhanced analytics for decision making: role of predictive modelling, and new AI technologies

• Implementing tailored strategies to foster active participation and feedback from patients throughout the trial duration
• Automating Collection of Patient Outcomes: Ensuring the integrity and reliability of collected data through quality control measures and leveraging advanced analytics
• Adhering to regulatory standards and Integrating ePRO and wearable data streams to gain a comprehensive understanding of patient experiences, behaviors, and health outcomes.
• Future-Proofing Research Methodologies: Adapting to emerging technologies to continuously enhance patient-centricity

This session provides an additional opportunity to meet with our product and solution providers in the exhibition hall to learn more about the products, technology,
and services that have been developed to solve some of your unique challenges. The technology demonstrations will last approximately 8 minutes on four cycles
with the opportunity to ask questions immediately afterwards over the refreshment break.

• Effective informed consent management for standardized and ethical clinical trials
• Reducing participant burden through digital accessibility, real-time support, and easy-to-use applications
• Assessing Site Readiness: Ensuring that platform aligns with the needs & preferences of trial sites and participants
• Optimizing consent documentation & ensuring compliance with regulatory standards

• Developing targeted outreach strategies leveraging social media and digital platforms to engage underrepresented communities in clinical trials
• Implementing user-friendly interfaces and providing necessary support to enhance digital literacy among participants
• Tailoring questionnaire design to accommodate diverse cultural backgrounds to reduce potential biases in data collection
• Combining structured and unstructured data from EHRs, and community health surveys with modern data fusion algorithms to create patient profiles

As the healthcare landscape continues to evolve, decentralization promises to reduce burden on both healthcare facilities and patients alike. However, there is also a danger that new challenges will emerge, potentially increasing burden in new areas. Therefore, it is critical to consider the quality and consistency of data collected across multiple sites, the different regulatory requirements, and the level of training and support required for staff and participants.

This discussion will explore the implications and opportunities of decentralized trials to determine whether they truly present the best ROI.

• Site Accessibility: How does the decentralization of clinical trials impact the accessibility of research sites for patients?
• Are decentralized trials facilitating or hindering patient recruitment efforts compared to traditional centralized or hybrid trials?
• Which group of stakeholders possesses the most potential to broaden acceptance of decentralized trials? Sponors/Sites/Patients/Tech vendors?
• Patient Engagement: How does the DCT’s influence patient engagement and retention throughout the study?
• Data Quality, Accuracy and Standardization: What measures are in place to ensure data quality and integrity in decentralized trials, and how does this affect the
overall burden on patients and sites?
• Have Health Authorities provided enough guidance on the conduct of decentralized trials?

All attendees are invited to attend our networking drinks reception at the end of the day’s proceedings. This is our way of saying thank you for your contribution and to create an additional opportunity to continue your discussions in an informal setting